03 FEB 2012 05:50                     MELAN ACCRUAL REPORT - OPEN and recently closed STUDIES                                     
                                                                                                                                  
                                         O                                               REGS. REGS. REGS. REGS. REGS.            
                                       R P                                                LAST  LAST  LAST  LAST  LAST  # of  # of
                                       E E                                   ACCR. TOTAL    12     6     3    30     7  ACT.  CURR
STUDY                                  G N ARM                                GOAL REGS. Month Month Month  DAYS  DAYS INSTs  IRBs
-------------------------------------- - - --------------------------------- ----- ----- ----- ----- ----- ----- ----- ----- -----
E1609-Adj Ipil AntiCTLA4 vs Interferon 1 E Total Registrations                        41    41    41    34    12     1   307   120
                                                                                   ----- ----- ----- ----- ----- -----            
                                                                                      41    41    41    34    12     1            
                                                                                                                                  
                                       * *                                   ***** -----                               ***** *****
                                       s                                              41                                          
                                                                                                                                  


































                                                                 

1 row selected.

03 FEB 2012 05:50                            MELAN Open Studies with No Registrations                                             
                                                                                                                                  
Study                                    Registration/Phase                  Open Date                                            
---------------------------------------- ----------------------------------- ---------                                            
E2607 Dasatinib in KIT+ pts w/Melanoma   1 Endorsed Study                    22-Nov-11                                            


















                                                                 

1 row selected.


no rows selected

SWOG StatCtr Home Page 1 row selected.